🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7550275

Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypep

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544486

Nell peptide expression systems and bone formation activity of nell peptide

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534604

Fusion polypeptides capable of activating receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534440

Fusion molecules and methods for treatment of immune diseases

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524516

Corrosion inhibiting mildew remover kit

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501260

Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatme

Precision Therapeutics, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491798

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, c

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488804

Modified fusion molecules for treatment of allergic disease

The Regents of the University of California · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473525

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Europe AG · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468394

Sterile pharmaceutical composition and process for a solution of propofol emulsion having

Amphastar Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468379

Inhibition of osteolytic lesions by SRC kinase inhibitors

The Board of Regents of the University of Texas System · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7449570

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

PTC THERAPEUTICS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427389

Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes

Provectus Pharmatech, Inc. · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423142

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420100

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410363

Electrical connector having compliant biasing device

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405233

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the t

PTC THERAPEUTICS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7399612

VEGF-binding fusion proteins and nucleic acids encoding the same

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396918

IGF-I fusion polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396682

Method for cell adhesion and wound healing

REGENBiotech, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396664

VEGF-binding fusion proteins and nucleic acids encoding the same

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7393544

Dispersion for pulmonary delivery of a bioactive agent

Nektar Therapeutics · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378273

Expression vectors

Gala Design, Inc. · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted